HMGA1 and cervical carcinoma: MiR-625 played tumor-suppressive roles in malignant tumor; miR-625-5p could target LRRC8E and highmobilitygroupAT-hook1 (HMGA1) in cervical cancer and BC, respectively [19, 20].